Rajeev M. Shah

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Rajeev M. Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajeev M. Shah:

Form 4 holding Director

Kala Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
10,894,613
Estimated value
$73,429,692
Report date
17 Jun 2021
Price
$6.74
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Solid Biosciences Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
30,000
Estimated value
Report date
16 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Black Diamond Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,500
Estimated value
Report date
16 May 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Satsuma Pharmaceuticals, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
0
Estimated value
Report date
06 Jun 2023
Price
$0.9100
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Rajeev M. Shah

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .